Reasearch Awards nomination

Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Research

Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients

Liang Liu123, Zhaozhe Liu1, Shuxian Qu1, Zhendong Zheng1, Yongye Liu1, Xiaodong Xie1* and Fulin Song4*

Author affiliations

1 Department of Oncology, Cancer Center of General Hospital of Shenyang Military Region, Shenyang 110840, China

2 Liaoning Medical University, Jinzhou 121001, China

3 Department of Oncology, Weifang People's Hospital, Weifang, 261041, China

4 Department of Pathology, General Hospital of Shenyang Military Region, Shenyang, 110840, China

For all author emails, please log on.

Citation and License

Diagnostic Pathology 2013, 8:71  doi:10.1186/1746-1596-8-71

Published: 1 May 2013

Abstract

Background

Small breast epithelial mucin (SBEM) has been implicated in tumor genesis and micrometastasis in breast cancer. Triple-negative breast cancer (TNBC) was characterized by high incidence in young women,early relapse and a very poor prognosis. The aim of this study was to evaluate the association of SBEM expression in tissues of TNBC with disease-free survival (DFS) and overall survival (OS).

Methods

SBEM protein expression was detected in 87 available formalin-fixed paraffin-embedded (FFPE) tissue specimens from TNBC patients by means of immunohistochemistry (IHC). We analyzed the correlation between the SBEM protein expression and DFS and OS during a 5 year follow-up period, respectively. And a SBEM cut-off value of prognosis was established associated with DFS and OS. SBEM was analyzed against other risk factors in multivariate analysis.

Results

SBEM 3+ score was cut-off value of prognosis and significantly correlated with DFS (p = 0.000) and OS (p = 0.001) in TNBC patients. There was a marked associations (p <0.05) between SBEM 3+ score and tumor size, grade, node status, TNM stage and Ki67. Multivariate analysis showed that patients with SBEM 3+ represented a higher risk of recurrence and mortality than those with a lower SBEM expression (HR = 3.370 with p = 0.008 for DFS and HR = 4.185 with p = 0.004 for OS).

Conclusions

SBEM is an independent risk predictor and may offer utility as a prognostic marker in TNBC patients.

Virtual Slides

http://www.diagnosticpathology.diagnomx.eu/vs/1624613061936917 webcite

Keywords:
SBEM; DFS; OS; IHC; TNBC